SCHEMBL9264253

SCHEMBL9264253

CC(C)(C)[Si](C)(C)OCC1CC(O)CC(=O)O1

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 3/20 0.43
HMGCR P04035 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13260909 0.84 HMGCR (0.41) HMGCR
SCHEMBL20211424 0.84 TOP2A (0.45) TOP2A
SCHEMBL9287478 0.82 TOP2A (0.39) TOP2AHMGCR
SCHEMBL9274773 0.81 TOP2A (0.36) TOP2A
SCHEMBL9270300 0.81 TOP2A (0.36) TOP2AHMGCR
SCHEMBL23992669 0.80 TOP2A (0.34) TOP2A
SCHEMBL19231350 0.80 TOP2A (0.34) TOP2A
SCHEMBL9274167 0.79 TOP2A (0.40) TOP2A
SCHEMBL9266676 0.79 TOP2A (0.40) TOP2A
SCHEMBL9343987 0.79 HMGCR (0.42) HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180072696-A1 SUBSTITUTED 3-HYDROXY-DELTA-LACTONES FROM EPOXIDES NATIONAL SCIENCE FOUNDATION 2018-03-15 US disclosed
US-20140107339-A1 SUBSTITUTED 3-HYDROXY-DELTA-LACTONES FROM EPOXIDES CORNELL UNIVERSITY (US) 2014-04-17 US disclosed
US-8530677-B2 Substituted 3-hydroxy-delta-lactones from epoxides CORNELL UNIVERSITY (US) 2013-09-10 US disclosed
US-20100145046-A1 Substituted 3-hydroxy-delta-lactones from epoxides ENERGY, UNITED STATES DEPARTMENT OF 2010-06-10 US disclosed
US-20100145046-A1 Substituted 3-hydroxy-delta-lactones from epoxides ENERGY, UNITED STATES DEPARTMENT OF 2010-06-10 US disclosed
US-5443970-A SEPARATION OF ISOMERS IN A MIXTURE BY SELECTIVE REACTION ZENECA LIMITED (GB) 1995-08-22 US disclosed
EP-0604483-A1 PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY PURE 4-HYDROXYTETRAHYDRO-2-PYRANONE DERIVATIVES ZENECA LIMITED (GB) 1994-07-06 EP disclosed
WO-1993006235-A1 PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY PURE 4-HYDROXYTETRAHYDRO-2-PYRANONE DERIVATIVES ZENECA LIMITED (GB) 1993-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100145046-A1 Substituted 3-hydroxy-delta-lactones from epoxides EBP, CYP8B1, HSD3B2 TOP2A 550/4885HMGCR 160/4885
US-20180072696-A1 SUBSTITUTED 3-HYDROXY-DELTA-LACTONES FROM EPOXIDES EBP, CYP8B1, HSD3B2 TOP2A 550/4885HMGCR 160/4885
US-20140107339-A1 SUBSTITUTED 3-HYDROXY-DELTA-LACTONES FROM EPOXIDES EBP, CYP8B1, HSD3B2 TOP2A 550/4885HMGCR 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.